Ne govorimo samo o promeni hrane koja se jede, ve i o menjanju naina razmiljanja o hrani , stvaranju pozitivnog i izbalansiranog odnosa prema hrani koji nee ukljuivati prejedanje, niti strah ili uzdravanje od hrane
Retatrutide Weight Loss Results Phase 2 trial data published in 2023 showed that retatrutide at the 12 mg dose produced an average weight loss of approximately 24.2% at 24 weeks , with projections suggesting that the loss could approach 2829% at 48 weeks based on the observed trajectory
The recovery piece surprised me too
Cardiovascular Benefits Retatrutide treatment produces comprehensive improvements in cardiovascular risk factors
The current FDA commissioner has been supportive of obesity drug development, but political changes are unpredictable
The most common adverse effects are gastrointestinal in nature, including diarrhea, constipation, abdominal cramping, and flatulence